1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow KK-LC-1 TCR: new trials by email Literature Review of KK-LC-1 TCR trials Research Report on KK-LC-1 TCR
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer KK-LC-1 TCR-T cells, Aldesleukin - Gastric Cancer, Breast Cancer | Phase 1 | Recruiting | Christian Hinrichs | 30 | 2022-09-26 | 2026-08-25 |
| T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers IL-2 (Aldesleukin), Cyclophosphamide, KK-LC-1 TCR - Kita-kyushu Lung Cancer Antigen 1, Human | Phase 1 | Terminated | National Cancer Institute (NCI) | 36 | 2022-03-08 | 2025-12-02 |
Breast Neoplasms (1) · Carcinoma (1) · Lung Neoplasms (1) · Neoplasm Metastasis (1) · Stomach Neoplasms (1) · Triple Negative Breast Neoplasms (1) · Uterine Cervical Neoplasms (1)
Christian Hinrichs (1) · National Cancer Institute (NCI) (1)
United States (2)